Endovascular Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in Pulmonary Embolism: Insights from the National Readmission Database.

Abstract

Introduction: Catheter-based therapies for pulmonary embolism (PE), including endovascular mechanical thrombectomy (MT) and catheter-directed thrombolysis (CDT) are increasingly being used in clinical practice. However, real-world comparative data between these two modalities are scarce. We aimed to evaluate and compare the outcomes of MT and CDT in patients with PE.

Methods: This retrospective cohort study utilized the 2021 National Readmission Database (NRD) to identify adults with a primary diagnosis of PE who underwent either MT or CDT. The primary outcome was in-hospital mortality, while secondary outcomes included major bleeding, cardiac arrest, vascular complications, and post-discharge readmissions. Propensity-score matching was applied, followed by logistic and Cox proportional hazard regression analyses. Subgroup analyses were conducted based on hospital procedural volume.

Results: After propensity-score matching, 7,376 patients who underwent MT and 7,355 who underwent CDT were included. MT was associated with higher odds of in-hospital mortality (4.4% vs. 3.4%; OR: 1.31, 95% CI: 1.01-1.68; p=0.04) and major bleeding (6.3% vs. 3.6%; OR: 1.79, 95% CI: 1.39-2.32; p<0.001) compared to CDT. No significant differences were observed in post-discharge mortality, although all-cause readmissions were higher in the MT group. Higher hospital procedural volume was associated with lower in-hospital mortality and lower major bleeding rates in both MT and CDT.

Conclusions: Endovascular CDT was associated with lower in-hospital mortality and major bleeding compared to MT in PE. As hospital procedural volume increased, both these outcomes improved, with reduced difference between MT and CDT.